News & Analysis on Clinical Trial Services & Contract Research And Development
The decision of the US Supreme Court not to hear Amgen's appeal in a patent infringement case against Sanofi-Aventis and Shire, involving the anaemia drug Epogen (epoetin alfa), may weaken Amgen's position in keeping another rival off the US market.
Swiss contract manufacturer Lonza has decided to merge its US microbial biopharma business activities in a single location, three months after buying Cambrex's biopharma unit.
Advanced Research Technologies (ART) has launched a new imaging system for studying molecular events in small living animals to further our understanding of disease and treatment mechanisms.
Clinsys Clinical Research, BioReliance Corporation, InVentiv Health, PRA International, Kendle, Parexel, PPD, Wyeth and PharmaNet have all had people on the move in the world of pharmaceutical outsourcing.
US company Digestive Care (DCI) is quadrupling its manufacturing, research and development capacity following an increase in demand for its drug Pancrecarb (pancrelipase).
Siemens is offering software support for the implementation of Process Analytical Technology (PAT) in the pharmaceutical industry with the launch of its Sipat package.
UK company SkyePharma's GeoMatrix technology has been used to develop a new formulation of a hypertension drug which can provide lower drug doses.
Massachusetts-based Avecia OligoMedicines has announced an expansion of its manufacturing facilities to accommodate increased production plans.
The critical role transgenic animals could play in the future of biopharmaceutical production has been tackled by a task force in a new report out this week.
A company that specialises in designing first-in-class small molecule drugs that modulate ion channels has been given an award for its innovative preclinical research.
Thermo Fisher Scientific and Sartorius have signed a supply agreement continuing the relationship between Sartorius and Thermo's recently acquired TC Tech.